title: Coronary mortality in China: fence, ambulance, or hospital treatments?
authors.affiliation: National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD.
authors.forename: George A
authors.initials: GA
authors.lastname: Mensah
authors.forename: Uchechukwu K A
authors.initials: UK
authors.lastname: Sampson
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D003327:Coronary Disease / Q000401:mortality*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000191:economics*
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D001241:Aspirin
keywords: China; Editorials; cardiovascular diseases; coronary disease; decision modeling; prevention and control